| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A comprehensive targeted next‐generation sequencing panel for genetic diagnosis of patients with suspected inherited thrombocytopenia
|
Johnson, Ben
|
|
|
2 |
4 |
p. 640-652
|
artikel
|
| 2 |
Adrenaline enhances in vitro platelet activation and aggregation in blood samples from ticagrelor‐treated patients
|
Singh, Sukhi
|
|
|
2 |
4 |
p. 718-725
|
artikel
|
| 3 |
A multicenter study to evaluate automated platelet aggregometry on Sysmex CS‐series coagulation analyzers—preliminary findings
|
Platton, Sean
|
|
|
2 |
4 |
p. 778-789
|
artikel
|
| 4 |
Analysis of procoagulant phosphatidylserine‐exposing platelets by imaging flow cytometry
|
Reddy, Emily C.
|
|
|
2 |
4 |
p. 736-750
|
artikel
|
| 5 |
Cancer‐associated thrombosis: The search for the holy grail continues
|
Ünlü, Betül
|
|
|
2 |
4 |
p. 622-629
|
artikel
|
| 6 |
Comparison of antithrombin‐dependent and direct inhibitors of factor Xa or thrombin on the kinetics and qualitative characteristics of blood clots
|
Salta, Stella
|
|
|
2 |
4 |
p. 696-707
|
artikel
|
| 7 |
Differences in von Willebrand factor function in type 2A von Willebrand disease and left ventricular assist device‐induced acquired von Willebrand syndrome
|
Deconinck, Shannen
|
|
|
2 |
4 |
p. 762-766
|
artikel
|
| 8 |
Diversity and inclusion in a new medical journal: Advancing science in the 21st century
|
Cushman, Mary
|
|
|
2 |
4 |
p. 620-621
|
artikel
|
| 9 |
Evaluation of a semi‐automated von Willebrand factor multimer assay, the Hydragel 5 von Willebrand multimer, by two European Centers
|
Bowyer, Annette E.
|
|
|
2 |
4 |
p. 790-799
|
artikel
|
| 10 |
Genomics and transcriptomics of megakaryocytes and platelets: Implications for health and disease
|
Fisher, Marlie H.
|
|
|
2 |
4 |
p. 630-639
|
artikel
|
| 11 |
Identification and characterization of novel mutations implicated in congenital fibrinogen disorders
|
Smith, Natalie
|
|
|
2 |
4 |
p. 800-811
|
artikel
|
| 12 |
Impact of your results: Beyond the relative risk
|
Siegerink, Bob
|
|
|
2 |
4 |
p. 653-657
|
artikel
|
| 13 |
Indoleamine 2,3‐dioxygenase 1 in coronary atherosclerotic plaque enhances tissue factor expression in activated macrophages
|
Watanabe, Yuki
|
|
|
2 |
4 |
p. 726-735
|
artikel
|
| 14 |
In silico thrombin generation: Plasma composition imbalance and mortality in human immunodeficiency virus
|
Brummel‐Ziedins, Kathleen E.
|
|
|
2 |
4 |
p. 708-717
|
artikel
|
| 15 |
ISSUE INFORMATION
|
|
|
|
2 |
4 |
p. 615-619
|
artikel
|
| 16 |
Management of anticoagulation for cancer‐associated thrombosis in patients with thrombocytopenia: A systematic review
|
Samuelson Bannow, Bethany R.
|
|
|
2 |
4 |
p. 664-669
|
artikel
|
| 17 |
Measurement of coagulation factors during rivaroxaban and apixaban treatment: Results from two crossover trials
|
Scheres, Luuk J.J.
|
|
|
2 |
4 |
p. 689-695
|
artikel
|
| 18 |
Meta‐analysis: Key features, potentials and misunderstandings
|
Dekkers, Olaf M.
|
|
|
2 |
4 |
p. 658-663
|
artikel
|
| 19 |
Peak plasma concentration of direct oral anticoagulants in obese patients weighing over 120 kilograms: A retrospective study
|
Piran, Siavash
|
|
|
2 |
4 |
p. 684-688
|
artikel
|
| 20 |
Preoperative screening for bleeding disorders: A comprehensive laboratory assessment of clinical practice
|
Vries, Minka J.
|
|
|
2 |
4 |
p. 767-777
|
artikel
|
| 21 |
Protein S K196E mutation reduces its cofactor activity for APC but not for TFPI
|
Maruyama, Keiko
|
|
|
2 |
4 |
p. 751-756
|
artikel
|
| 22 |
Salivary tissue factor induces thrombin generation in a diurnal rhythm
|
van der Vorm, Lisa N.
|
|
|
2 |
4 |
p. 757-761
|
artikel
|
| 23 |
Serial imaging after pulmonary embolism and correlation with functional limitation at 12 months: Results of the ELOPE Study
|
Ma, Kim A.
|
|
|
2 |
4 |
p. 670-677
|
artikel
|
| 24 |
Systematic review of fondaparinux for heparin‐induced thrombocytopenia: When there are no randomized controlled trials
|
Linkins, Lori‐Ann
|
|
|
2 |
4 |
p. 678-683
|
artikel
|
Tijdschrift beschrijving